Carregant...
EXTH-39. EFFICACY OF THE ANTIBODY-DRUG CONJUGATE ABT-414 IN BRAIN TUMOR MODELS
Brain tumor treatment is limited by a lack of effective therapies and inadequate drug delivery across the blood-brain barrier (BBB). The antibody-drug conjugate (ADC) ABT-414 (AbbVie Pharmaceuticals) couples the toxin monomethyl auristatin F to a humanized monoclonal antibody targeting overexpressed...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692295/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.331 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|